期刊文献+

以水肿为首发症状的POEMS综合征1例报告 被引量:2

One Case Report of POEMS Syndrome with Edema as the Initial Manifestation
下载PDF
导出
摘要 目的:了解POEMS综合征临床特点及诊疗思路;方法:对1例以水肿为临床表现的POEMS综合征进行临床分析及近几年临床文献复习;结果:患者存在双下肢凹陷性水肿,慢性进展性感觉运动性多发性神经表现,伴有色素沉着、多毛、白甲等皮肤改变,辅助检查提示肝脾等器官肿大,甲状腺功能减退,硬化性骨改变,Ig A、λ泳道发现异常单克隆免疫球蛋白,最终诊断为POEMS综合征;结论:POEMS综合征误诊率极高,且预后差,治疗方案仍在进一步研究中,早期的诊断对提高患者的生存率及改善患者的生活质量是及其重要的。 Objective: To summarize the clinical features and diagnosis and treatment of POEMS syndrome. Methods:Clinical analysis of 1 cases of POEMS syndrome with edema as a clinical manifestation and review of clinical literature in recent years.Results The patient presented with sunken edema of both lower extremities and chronic progressive sensorimotor multiple nerve manifestations, Accompanied by pigmentation, hirsutism, white nails and other skin changes,combined assisted examination diagnosed POEMS syndrome. Conclusion: The misdiagnosis rate of POEMS syndrome is very high, early diagnosis is important for improving patient survival and improving patient quality of life.
作者 马盈盈 陈怀珍 MA Yingying;CHEN Huaizhen(Anhui University of Chinese Medicine,Anhui Hefei 230038,China;The First Affiliated Hospital of Anhui Chinese Medicine University,Anhui Hefei 230031,China)
出处 《中医药临床杂志》 2018年第6期1047-1049,共3页 Clinical Journal of Traditional Chinese Medicine
基金 国家中医药管理局重点专科(201232)
关键词 POEMS综合征 水肿 多发性周围神经病 M蛋白 多系统损害 POEMS syndrome Edema Polyneuropathy Monoclonal protein Multiplesystem lesions
  • 相关文献

参考文献5

二级参考文献75

  • 1鲁瑾,邹大进.POEMS综合征的内分泌表现及预后分析[J].上海医学,2004,27(6):403-405. 被引量:4
  • 2邹琼,孙斌,谢慧君,张家和,马烈.POEMS综合征的骨髓病理学表现[J].中国临床神经科学,2005,13(4):380-384. 被引量:2
  • 3Churchill AJ, Carter JG, Lovell HC, et al. VEGF polymorphisms are associated with neovascular age-related maeular degeneration [J]. Hum Mol Genet,2006,15(19) :2955-2961.
  • 4Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration[J]. N Engl J Meal,2006,355(14) .. 1432-1444.
  • 5Rosenfeld PJ,Brown DM, Heier JS, et al. Ranibizumab for neo- vascular age-related macular degeneration [J]. N Engl J Med, 2006,355(14) : 1419-1431.
  • 6Ashikari M, Tokoro M, Itaya M, et al. Suppression of laser-in- duced ehoroidal neovascuIarization by nontargeted siRNA[J]. In- vest Ophthalmol Vis Sei, 2010,51 (7) : 3820-3824.
  • 7Rajappa M, Saxena P, Kaur J. Ocular angiogenesis mechanisms and recent advances in therapy[J]. Adv Clin Chem, 2010,50.. 103- 121.
  • 8Bhisitkul RB. Vascular endothelial growth factor biology: clinical implications for ocular treatments[J]. Br J Ophthalmol, 2006, 90 (12) 1542-1547.
  • 9Cunningham El" Jr, Adamis AP, Altaweel M, et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular en- dothelial growth factor aptamer, for diabetic macular edema[J]. Ophthalmology, 2005,112(10) : 1747-1757.
  • 10Golf MJ, Johnson RN, McDonald HR, et al. Intravitreal bevaci- zumab for previously treated choroidal neovaseularization from age-related maeular degeneration[J]. Retina, 2007,27 (4) 432-438.

共引文献32

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部